Transgenic non-human animals expressing human blood clotting factors

Details for Australian Patent Application No. 2008347321 (hide)

Owner Baxter Healthcare S.A. Baxter International Inc.

Inventors Sasgary, Maria; Antoine, Gerhard; Schwarz, Hans-Peter; Ehrlich, Hartmut; Schuster, Maria; Reipert, Birgit

Agent Cullens

Pub. Number AU-A-2008347321

PCT Pub. Number WO2009/088876

Priority 61/017,920 31.12.07 US

Filing date 30 December 2008

Wipo publication date 16 July 2009

International Classifications

C12N 15/85 (2006.01) Mutation or genetic engineering - for animal cells

A01K 67/027 (2006.01) Rearing or breeding animals, not otherwise provided for - New breeds of vertebrates

A61K 49/00 (2006.01) Preparations for testing

C07K 14/745 (2006.01) Peptides having more than 20 amino acids

C07K 14/755 (2006.01) Peptides having more than 20 amino acids

C12N 9/64 (2006.01) Enzymes, e.g. ligases (6.) - derived from animal tissue, e.g. rennin

G01N 33/50 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

Event Publications

22 July 2010 PCT application entered the National Phase

  PCT publication WO2009/088876 Priority application(s): WO2009/088876

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008347346-Method for reading attributes from an ID token

2008347315-Batch-operated reverse osmosis system with multiple membranes in a pressure vessel